| TC | Stat | Stk | Ins | Fil | +d | +w | +m | +q | +h | +y | avg | 
|---|
| Filing Date | T Date | Ticker | Issuer | Inc | Sector | Ind | Industry | Owner | oSt | Rel | Title | T | TVal | Price | L | Qty | oc | Own | H | r2y | r1y | r6m | r3m | r6w | r3w | r7d | r3d | f1d | f1w | f1m | f3m | f6m | f1y | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/19/24 17:43 | 11/15/24 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Olivo Alicia C | FL | O | GC | S.d | -79 | 15.36 | 0 | -5 | -12 | 37 | D | ||||||||||||||
| 8/19/24 16:17 | 8/15/24 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Olivo Alicia C | FL | O | GC | S.d | -17 | 16.05 | 0 | -1 | -2 | 44 | D | ||||||||||||||
| 5/17/24 16:07 | 5/15/24 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Olivo Alicia C | FL | O | GC | S.d | -17 | 15.74 | 0 | -1 | -2 | 45 | D | ||||||||||||||
| 2/20/24 16:32 | 2/15/24 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Olivo Alicia C | FL | O | GC | S.d | -39 | 14.96 | 0 | -3 | -7 | 35 | D | ||||||||||||||
| 11/20/23 16:33 | 11/17/23 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Olivo Alicia C | FL | O | GC | S.d | -49 | 18.39 | 0 | -3 | -7 | 37 | D | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |